← Back to Search

Behavioral Intervention

Digital Mental Health Intervention for Depression in Cancer Survivors

N/A

Recruiting

Led By Jennifer Dahne, PhD

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

age 18+

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up study duration (6-7 months or until recruitment is reached)

Awards & highlights

Study Summary

This trial is testing a mobile app to help treat depression in cancer survivors. Participants may get the mobile app or standard care. They'll complete questionnaires to assess progress. Risks include data breach and loss of confidentiality.

Who is the study for?

This trial is for adults over 18 with cancer who are experiencing depression, as indicated by a score of ≥10 on the PHQ-9. Participants must own a smartphone, have an email or text messaging access, and be willing to use an app for mood treatment. Those with severe cognitive issues or current suicidal thoughts cannot join.Check my eligibility

What is being tested?

The study tests 'Moodivate', a mobile app designed to help cancer survivors manage depression. Two-thirds of participants will use the app while one-third will not (treatment as usual). The trial involves completing questionnaires over four weeks to monitor depressive symptoms and user experience.See study design

What are the potential side effects?

Potential risks include frustration, increased emotional distress, data breach risk, and loss of confidentiality. If these occur or if Moodivate isn't suitable, alternative options involve seeking care from primary healthcare providers or oncology teams.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ study duration (6-7 months or until recruitment is reached)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~study duration (6-7 months or until recruitment is reached)

This trial's timeline: 3 weeks for screening, Varies for treatment, and study duration (6-7 months or until recruitment is reached) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Accrual

Trial Design

2Treatment groups

Experimental Treatment

Group I: Treatment as UsualExperimental Treatment1 Intervention

Participants in the treatment as usual group will be provided educational material about mood management available via the EHR with the suggestion to discuss questions with their oncology provider. Participants will be asked to complete questionnaire measures weekly for 4 weeks following study enrollment.

Group II: MoodivateExperimental Treatment1 Intervention

Participants randomized to the Moodivate condition will be instructed to utilize Moodivate regularly, at least once per day, for the treatment of depressed mood among cancer survivors. Participants in the Moodivate group will receive a download code to download the Moodivate mobile application. Moodivate is a mobile app for individuals with elevated symptoms of depression. Within the app, users identify values, create activities, schedule activities, and rate mood daily. Participants will be asked to complete questionnaire measures weekly for 4 weeks following study enrollment.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Behavioral Activation Therapy app

2021

N/A

~110

Treatment as Usual

2016

Completed Phase 3

~2710

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor

933 Previous Clinical Trials

7,394,621 Total Patients Enrolled

40 Trials studying Depression

6,938 Patients Enrolled for Depression

Jennifer Dahne, PhDPrincipal InvestigatorMedical University of South Carolina

3 Previous Clinical Trials

920 Total Patients Enrolled

3 Trials studying Depression

920 Patients Enrolled for Depression

Media Library

Behavioral Activation Therapy app (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05932810 — N/A

Depression Research Study Groups: Treatment as Usual, Moodivate

Depression Clinical Trial 2023: Behavioral Activation Therapy app Highlights & Side Effects. Trial Name: NCT05932810 — N/A

Behavioral Activation Therapy app (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05932810 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open presently for this experiment?

"As indicated on clinicaltrials.gov, this study is looking for participants and was first posted on May 5th 2023 with the most recent update taking place June 27th of that same year."

Answered by AI

Could you provide an estimate of the number of participants involved in this experiment?

"Affirmative. Records available on clinicaltrials.gov confirm that this trial, which was initially shared on May 5th 2023, is actively searching for volunteers. To reach their quota of 15 participants, only one medical center needs to be visited."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living With Cancer

Jennifer Dahne 2023. "Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living With Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05932810.

All > Depression Columbia